HEIM (Health Equity Informative Metrics) Framework

In a world where medical research shapes lives, who benefits shouldn’t be left to chance.

HEIM measures research equity across the full biomedical pipeline — from discovery and clinical trials to scientific knowledge. It reveals where research aligns with real global health needs — and where it doesn’t. Accurate. Transparent. Actionable.

​

1. Discovery — identifying gaps in biobank and genomic research coverage for high-burden diseases.

2. Translation — ensuring that clinical trials match actual disease needs, across regions and populations.

3. Knowledge Connectivity — breaking down barriers by showing how well research on a condition connects to the broader scientific community.

 

With HEIM, stakeholders can see inequity where it happens — like conditions with high burden but low research attention — and make informed decisions to correct it.

​

Whether you are a health funder, a research institution, or an innovator in biotech, HEIM gives you the insights to catalyze change.

​

Read our publication on the 'Three Dimensions of Compounding Neglect: How Biobanks, Clinical Trials, and Scientific Literature Systematically Exclude the Global South' and the creation of the HEIM tool.